#curesnotcuts

Dear Research Advocate: The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word! One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open...
Dear Research Advocate: The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word! One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open...
The August congressional recess is here! Members of Congress are back home for the month long break. Now’€™s the time to speak up and urge policy makers to make research for health a higher national priority before they return to Capitol Hill and make decisions that will affect the health and prosperity of our nation. Join Research!America’€™s social media congressional recess campaign, Medical Research is at Risk. We Need Cures, Not Cuts! Customize your messages with statistics, patient/researcher stories, examples of innovative research, and descriptions of the impact of sequestration to help make research part of the national conversation on social media and beyond. Follow us on Twitter...
The August congressional recess is here! Members of Congress are back home for the month long break. Now’€™s the time to speak up and urge policy makers to make research for health a higher national priority before they return to Capitol Hill and make decisions that will affect the health and prosperity of our nation. Join Research!America’€™s social media congressional recess campaign, Medical Research is at Risk. We Need Cures, Not Cuts! Customize your messages with statistics, patient/researcher stories, examples of innovative research, and descriptions of the impact of sequestration to help make research part of the national conversation on social media and beyond. Follow us on Twitter...
Dear Research Advocate: Myth #1: Congress doesn’t pay attention during the August recess. Not true! Many town hall meetings are planned. Since the debt ceiling and appropriations negotiations are coming up in September, the August recess is actually a very important time for advocacy. Use this month to drive the point home that medical research should not be subjected to budget cuts by attending a town hall meeting, meeting with district staff and participating in our social media campaign, #curesnotcuts. Click here for sample messages, or draw from a recent op-ed penned by The Honorable John Edward Porter, Research!America chair. The op-ed ran in several McClatchy-Tribune newspapers across...
Dear Research Advocate: Myth #1: Congress doesn’t pay attention during the August recess. Not true! Many town hall meetings are planned. Since the debt ceiling and appropriations negotiations are coming up in September, the August recess is actually a very important time for advocacy. Use this month to drive the point home that medical research should not be subjected to budget cuts by attending a town hall meeting, meeting with district staff and participating in our social media campaign, #curesnotcuts. Click here for sample messages, or draw from a recent op-ed penned by The Honorable John Edward Porter, Research!America chair. The op-ed ran in several McClatchy-Tribune newspapers across...
We NEED CURES, NOT CUTS Sequestration’€™s arbitrary, across-the-board budget cuts to defense and non-defense spending have ravaged (and will continue to ravage) our research enterprise. Sequestration and the inability of Congress to pass a budget will dramatically reduce funding for medical research and critical public health functions for years to come. Funding cuts are stopping highly promising research in its tracks, squandering exciting new potential for treatments and cures for millions of Americans who are waiting for them. We can’€™t let this continue. Deficit reduction is important, but there are ways to achieve it that do not compromise American lives and American competitiveness...
We NEED CURES, NOT CUTS Sequestration’€™s arbitrary, across-the-board budget cuts to defense and non-defense spending have ravaged (and will continue to ravage) our research enterprise. Sequestration and the inability of Congress to pass a budget will dramatically reduce funding for medical research and critical public health functions for years to come. Funding cuts are stopping highly promising research in its tracks, squandering exciting new potential for treatments and cures for millions of Americans who are waiting for them. We can’€™t let this continue. Deficit reduction is important, but there are ways to achieve it that do not compromise American lives and American competitiveness...
Dear Research Advocate: This week the Senate Appropriations Committee voted to increase NIH funding by $307 million in FY14, an increase largely due to the unwavering support of Labor-HHS subcommittee Chair Tom Harkin and Appropriations Committee Chair Barbara Mikulski. The Senate bill also increases funding for the CDC by $1.6 billion over FY13. It is important to note that the Senate bill does not include sequestration reductions, but Mikulski has vowed to fight these dangerous, continued cuts. (See my brief statement on this week’€™s Senate action.) We all realize that these proposed funding levels are not adequate to capitalize on the current opportunity in science and respond robustly...
Dear Research Advocate: This week the Senate Appropriations Committee voted to increase NIH funding by $307 million in FY14, an increase largely due to the unwavering support of Labor-HHS subcommittee Chair Tom Harkin and Appropriations Committee Chair Barbara Mikulski. The Senate bill also increases funding for the CDC by $1.6 billion over FY13. It is important to note that the Senate bill does not include sequestration reductions, but Mikulski has vowed to fight these dangerous, continued cuts. (See my brief statement on this week’€™s Senate action.) We all realize that these proposed funding levels are not adequate to capitalize on the current opportunity in science and respond robustly...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient